Published in Am J Public Health on January 31, 2007
Drugscapes and the role of place and space in injection drug use-related HIV risk environments. Int J Drug Policy (2008) 1.29
The law (and politics) of safe injection facilities in the United States. Am J Public Health (2008) 1.28
Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico. Int J Drug Policy (2008) 1.27
Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need. J Urban Health (2009) 1.19
HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002. J Urban Health (2008) 1.14
Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends. J Urban Health (2008) 1.13
Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. Int J Drug Policy (2008) 1.02
Environmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992-2002. Drug Alcohol Depend (2009) 0.99
Conflict transformation, stigma, and HIV-preventive structural change. Am J Community Psychol (2012) 0.92
The HIV Epidemic: High-Income Countries. Cold Spring Harb Perspect Med (2012) 0.90
PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives. Subst Abuse Treat Prev Policy (2015) 0.88
"Discredited" Versus "Discreditable": Understanding How Shared and Unique Stigma Mechanisms Affect Psychological and Physical Health Disparities. Basic Appl Soc Psych (2013) 0.82
Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals? Ann Epidemiol (2014) 0.82
Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing. Subst Use Misuse (2011) 0.80
A qualitative assessment of stakeholder perceptions and socio-cultural influences on the acceptability of harm reduction programs in Tijuana, Mexico. Harm Reduct J (2008) 0.78
The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California. Soc Work Public Health (2016) 0.77
Lessons learned from a peri-urban needle exchange. Harm Reduct J (2010) 0.77
Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research. Int J Drug Policy (2016) 0.77
Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993-2007. Am J Public Health (2015) 0.75
Drug-related deaths and the sales of needles through pharmacies. Drug Alcohol Depend (2014) 0.75
Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm Reduct J (2017) 0.75
Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States. Med Care (2014) 0.75
The case of a needle exchange policy debate in Fresno, California. Crit Soc Policy (2015) 0.75
The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health (1996) 9.20
High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol (1997) 6.49
Impure science: AIDS, activism, and the politics of knowledge. Med Soc (Berkeley) (1996) 6.02
The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study. Soc Sci Med (2005) 3.77
Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol (1997) 2.36
Community action against asthma: examining the partnership process of a community-based participatory research project. J Gen Intern Med (2003) 2.35
Embodied health movements: new approaches to social movements in health. Sociol Health Illn (2004) 2.35
The New York Needle Trial: the politics of public health in the age of AIDS. Am J Public Health (1991) 2.02
Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health (2001) 2.02
Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol (2001) 1.73
Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am J Public Health (1995) 1.72
Update: syringe exchange programs--United States, 2002. MMWR Morb Mortal Wkly Rep (2005) 1.42
Syringe exchange as a social movement: a case study of harm reduction in Oakland, California. Subst Use Misuse (1998) 1.14
The legality of selling or giving syringes to injection drug users. J Am Pharm Assoc (Wash) (2002) 1.07
Behavioral risk factors and human immunodeficiency virus (HIV) prevalence among intravenous drug users in Puerto Rico. Am J Epidemiol (1992) 1.05
What's community got to do with it? Implementation models of syringe exchange programs. AIDS Educ Prev (2005) 1.02
"If you want to sit on your butts you'll get nothing!" Community activism in response to threats of rural hospital closure in southern New Zealand. Health Place (2003) 1.00
HIV, AIDS and human services: exploring public attitudes in West Hollywood, California. Health Soc Care Community (2000) 0.94
Empirical science meets moral panic: an analysis of the politics of needle exchange. J Public Health Policy (2003) 0.91
Casey House: interpreting the location of a Toronto AIDS hospice. Soc Sci Med (1995) 0.89
A tale of two (low prevalence) cities: social movement organisations and the local policy response to HIV/AIDS. Soc Sci Med (1998) 0.88
From distributions of deviance to definitions of difference: past and future mental health geographies. Health Place (2000) 0.88
Point Defiance: a case study of the United States' first public needle exchange in Tacoma, Washington. Int J Drug Policy (2001) 0.84
Taking action in communities: women living with HIV/AIDS lead the way. J Community Health Nurs (2003) 0.81
Community support for needle exchange programs and pharmacy sale of syringes: a household survey in Baltimore, Maryland. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.81
The policy context for community development practice in public health: a Canadian case study. J Public Health Policy (2000) 0.79
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The social structural production of HIV risk among injecting drug users. Soc Sci Med (2005) 7.78
Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health (2006) 4.85
Doing harm reduction better: syringe exchange in the United States. Addiction (2009) 4.29
The differential effects of face-to-face and computer interview modes. Am J Public Health (2002) 4.13
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS (2006) 3.55
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol (2003) 3.29
A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr (2002) 3.20
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis (2011) 3.13
Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction (2004) 2.97
Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health (2004) 2.93
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS (2005) 2.91
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr (2004) 2.90
Alternatives to the randomized controlled trial. Am J Public Health (2008) 2.85
HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health (2005) 2.62
Transmission and prevention of HIV and sexually transmitted infections in war settings: implications for current and future armed conflicts. AIDS (2002) 2.54
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS (2007) 2.52
Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology (2004) 2.52
Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol (2008) 2.27
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health (2008) 2.23
A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. J Acquir Immune Defic Syndr (2002) 2.16
Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy (2008) 2.15
The psychology of preventing AIDS among intravenous drug users. A social learning conceptualization. Am Psychol (1988) 2.12
Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study. PLoS One (2013) 2.06
Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr (2002) 1.97
Emerging future issues in HIV/AIDS social research. AIDS (2006) 1.95
Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr (2006) 1.88
'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction (2007) 1.85
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (2002) 1.83
Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr (2002) 1.78
Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clin Infect Dis (2007) 1.77
Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. Int J Drug Policy (2006) 1.74
Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr (2005) 1.69
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr (2002) 1.68
Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach. Am J Public Health (2014) 1.62
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS One (2013) 1.61
Some data-driven reflections on priorities in AIDS network research. AIDS Behav (2007) 1.60
HIV prevalence rates among men who have sex with men in the southern United States: population-based estimates by race/ethnicity. AIDS Behav (2011) 1.59
Statewide estimation of racial/ethnic populations of men who have sex with men in the U.S. Public Health Rep (2011) 1.58
HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health (2003) 1.55
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health (2004) 1.49
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health (2009) 1.49
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy (2007) 1.48
Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend (2007) 1.47
Incarceration, sex with an STI- or HIV-infected partner, and infection with an STI or HIV in Bushwick, Brooklyn, NY: a social network perspective. Am J Public Health (2011) 1.46
Racial/ethnic disparities in injection drug use in large US metropolitan areas. Ann Epidemiol (2005) 1.43
Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend (2008) 1.41
Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat (2003) 1.41
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction (2007) 1.41
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend (2008) 1.41
A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat (2002) 1.40
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS (2005) 1.40
An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men. J Urban Health (2004) 1.38
Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (2012) 1.38
HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst Use Misuse (2011) 1.34
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health (2008) 1.33
Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health (2011) 1.32
HIV among injection drug users in large US metropolitan areas, 1998. J Urban Health (2005) 1.31
Correlates of HIV status among injection drug users in a border region of southern China and northern Vietnam. J Acquir Immune Defic Syndr (2005) 1.31
Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction (2003) 1.30
An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav (2013) 1.27
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health (2004) 1.26
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend (2007) 1.26
Social capital or networks, negotiations, and norms? A neighborhood case study. Am J Prev Med (2007) 1.24
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med (2009) 1.23
Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors. Health Place (2011) 1.23
Strategies to avoid opiate withdrawal: implications for HCV and HIV risks. Int J Drug Policy (2009) 1.23
Harnessing the power of social networks to reduce HIV risk. Focus (2005) 1.23
Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas. Am J Public Health (2006) 1.22
HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend (2010) 1.21
Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia. J Urban Health (2010) 1.21
Diffusion of the D.A.R.E and syringe exchange programs. Am J Public Health (2006) 1.20